Gilead’s lenacapavir applications for HIV gain EMA validation
The latest announcement follows the recent US Food and Drug Administration (FDA) acceptance of the company’s new drug ...
Morgan Stanley sees FDA approval of GILD's Lenacapavir
Morgan Stanley expects the FDA to approve Gilead Sciences (NASDAQ:GILD)' Lenacapavir (LEN) for HIV prevention (PrEP) on or before its June 19 PDUFA date, a move that the bank believes could drive ...
Trump’s Funding Cuts Halt Rollout Of HIV Prevention Drug
A groundbreaking injectable designed to curb the global spread of HIV is now at risk of being delayed due to Donald Trump's ...
Pharmabiz8h
EMA validates Gilead’s MAA and EU-Medicines for all application for twice-yearly lenacapavir for HIV prevention
Foster City, California Tuesday, February 25, 2025, 16:00 Hrs [IST] ...
Ads Popped Up on Drivers' Screens. There May Be More on the Way
When Jeep owners complained ads were appearing while driving, the carmaker said it was a glitch. But as auto makers consider ...
Anthropic Launches the World’s First ‘Hybrid Reasoning’ AI Model
Claude 3.7, the latest model from Anthropic, can be instructed to engage in a specific amount of reasoning to solve hard ...
Healio51m
Top in ID: Undetected bird flu cases in veterinarians; CDC officers remain in positions
Three bovine veterinarians had undetected H5N1 avian influenza infections despite no apparent contact with infected cows, ...
BlackDoctor22h
Health Equity is Profitable—So Why Isn’t It a Priority?
The discussion ended with a bold call to action for businesses, healthcare providers, and policymakers: health equity must be a priority—not just ethically, but economically. As Burgess put it: “This ...